Status:
COMPLETED
Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Adverse Effects
Aggression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
SSRIs are the first line of therapy for anxiety and depressive disorders and for many other clinical diagnoses. One of the most disturbing side effects that is observed is a tendency towards aggressiv...
Detailed Description
Selective serotonin reuptake inhibitors (SSRIs) became the first line therapy for anxiety and depressive disorders and for many other clinical diagnoses. One of the most disturbing side effects that i...
Eligibility Criteria
Inclusion
- Age above 18 years
- Instructed by his/her family physician to start taking a medicine in the SSRI group
Exclusion
- According to the family practitioner's record: under SSRI, SNRI, or NRI treatment during the previous 3 months or at the time of entry into the study.
- Diagnosed with schizophrenia or active psychosis or impaired judgment
- Anti-social personality disorder
- Drug use or alcohol abuse
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00361062
Start Date
September 1 2006
End Date
March 1 2012
Last Update
February 13 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
HaEmek Medical Center
Afula, Ysrael Valley, Israel, 18101
2
HaEmek Medical Center
Afula, Israel